We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Medium-sized Japanese drugmaker Chugai is forecasting record
profit this year, largely as a result of restructuring and the ongoing impact
of its 2002 merger with the local unit of Switzerland's Roche.
Indian low-cost drug producers are lamenting their restricted access
to the UAE's drugs market, citing the traditional dominance of branded ethical
products in the local sector.
The Brazilian government's new initiative to develop state-operated
drug distribution will offer generic medicines at prices up to 90% lower than
in privately-held outlets, according to the project's coordinator.
International reports have quoted Russia's health minister as saying
that the country's new drug reimbursement plans will channel state subsidies
directly from regional insurance funds to drug suppliers.
Hungary's government has halved its 15% price subsidy on reimbursed
drugs, which had been intended to compensate consumers after the failure of
its attempt to fix prices at 15% below April 2004 levels.
Japanese drug producer Daiichi has reported solid sales in
the first three quarters of its fiscal year, despite difficult conditions in
the domestic market.